Albert David (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Albert David Limited |
|||
|
Price: ₹1,308.75 | ||
| 52 Week Low: ₹959.70 52 Week High: ₹1,753.95 |
|||
| Market Capital: 762.19 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Albert David Share Price Target For 2024
- 1.1.1: Albert David Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Albert David Share Price Target For 2025
- 1.2.1: Albert David Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Albert David Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Albert David Brief Company Overview
- 4: Albert David Financial Performance
- 4.0.1: Is Albert David A Good Buy For Long Term?
To predict the Albert David's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Albert David Share Price Target For 2024
The line chart displays the monthly closing prices of Albert David with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Albert David shares in 2024, see the table below.
Albert David Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1376.55 (+5.18%) | Price Action: 17 Dec 2024 Low |
| 2024 Target 2 | 1362.0 (+4.05%) | Price Action: 08 Nov 2024 Low |
| 2024 Target 1 | 1348.35 (+3.02%) | Price Action: 18 Dec 2024 Low |
| Current Price | 1308.75 | Albert David's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1287.8 (-1.61%) | Price Action: 26 Nov 2024 High |
| Stop Loss 2 | 1270.0 (-2.97%) | Price Action: Oct 2024 Low |
| Stop Loss 3 | 1254.23 (-4.17%) | Price Action: Feb 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Albert David is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1349.17 serves as the nearest technical reference point.
Historical Returns: 3-month: -9.5% | 6-month: -2.33% | 1-year: +36.31%
Albert David Share Price Target For 2025
The line chart displays the monthly closing prices of Albert David with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Albert David shares in 2025, see the table below.
Albert David Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1915.37 (+46.35%) | Price Action: Chart |
| 2025 Target 2 | 1879.66 (+43.62%) | Price Action: Chart |
| 2025 Target 1 | 1861.05 (+42.2%) | Fibonacci Extension Level 64.90% |
| Current Price | 1308.75 | Albert David's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1149.77 (-12.15%) | Price Action: Jul 2024 Low |
| Stop Loss 2 | 1138.27 (-13.03%) | Price Action: Chart |
| Stop Loss 3 | 1117.78 (-14.6%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Albert David is currently trading at 43.9% of its 52-week range (₹959.7 - ₹1753.95).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +36.31% | 3-year: +132.34% | 5-year: +254.47%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Albert David Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,308.75 | ||
| 2024 | ₹1,477.34 | +12.88% | ₹1,499.50 |
| 2025 | ₹1,672.03 | +13.17% | ₹1,697.11 |
| 2026 | ₹1,883.34 | +12.63% | ₹1,911.59 |
| 2027 | ₹2,069.66 | +9.89% | ₹2,100.70 |
| 2028 | ₹2,344.58 | +13.28% | ₹2,379.75 |
| 2029 | ₹2,532.89 | +8.03% | ₹2,570.88 |
| 2030 | ₹2,717.32 | +7.28% | ₹2,758.08 |
| 2031 | ₹2,929.87 | +7.82% | ₹2,973.82 |
| 2032 | ₹3,104.71 | +5.96% | ₹3,151.28 |
| 2033 | ₹3,410.49 | +9.84% | ₹3,461.65 |
| 2034 | ₹3,588.45 | +5.21% | ₹3,642.28 |
| 2035 | ₹3,762.61 | +4.85% | ₹3,819.05 |
| 2036 | ₹3,976.41 | +5.68% | ₹4,036.06 |
| 2037 | ₹4,139.75 | +4.1% | ₹4,209.93 |
| 2038 | ₹4,476.41 | +8.13% | ₹4,543.56 |
| 2039 | ₹4,495.10 | +0.41% | ₹4,562.53 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Albert David Brief Company Overview
Albert David Limited OverviewAlbert David Limited is an esteemed pharmaceutical player in India, manufacturing and trading a diverse range of formulations, solutions, and medical disposables. Established in 1938, the company has a long-standing presence in the industry....
Headquartered in Kolkata, it operates across India and exports its products globally, notably to Latin America, Southeast Asia, and Africa. Albert David Limited's commitment to quality and innovation is reflected in its extensive product portfolio, encompassing parenterals, oral/enteral formulations, topical agents, and vision care products. Additionally, the company produces bulk drugs, disposable syringes, and needles, catering to diverse healthcare needs.Albert David Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 762.19 Crore | Market valuation of Albert David's shares. |
| Revenue (TTM) | 359.87 Crore | Total revenue generated by Albert David over the past twelve months. |
| Net Income (TTM) | +70.77 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -1.02% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +19.66% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-2.8% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-19.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.86 | Company's total debt divided by total shareholder equity. |
| Total Debt | 3.32 Crore | Sum of Albert David's current & long-term financial obligations. |
| Total Cash | 285.22 Crore | Total amount of liquid funds available to Albert David. |
| Beta | 0.4 | Beta is less than 1 indicating that the Albert David's price is less volatile than the market. |
Is Albert David A Good Buy For Long Term?
Albert David, a small-cap stock with a market capitalization of ₹762.19 crore, shows strong long-term growth potential. While Q1 2024-25 earnings decreased 19.8% year-over-year and revenue slightly dipped 2.8% quarter-over-quarter, its robust profit margin of 19.66% and substantial cash balance of ₹285.22 crore are positive indicators. Past performance, with 5-year returns exceeding 210.86%, is impressive. However, the recent 3-month return of -2.91% warrants caution. Considering the overall picture, it's a good buy for long-term investors with a moderate risk tolerance.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
